Now available TEPMETKO®

TEPMETKO® (tepotinib) is a kinase inhibitor indicated for the treatment of adult patients with metastitic non-small cell
lung cancer (NSCLC) harboring mesenchymalepithelial transition (MET) exon 14 skipping alterations.